Abstract
In the drug-eluting stent (DES) era, some situations continue to be associated with a high risk of restenosis or stent thrombosis. We sought to assess the efficacy and safety of a new paclitaxel-coated, drug-eluting balloon (DEB) in such cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
